Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.810
0.00 (0.00%)
At close: Sep 17, 2026, 4:00 PM EDT
1.805
-0.005 (-0.27%)
After-hours: Sep 17, 2026, 4:57 PM EDT
Kairos Pharma Employees
As of December 31, 2025, Kairos Pharma had 4 total employees, including 1 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,451,250
Market Cap
6.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 1 | 3 |
| Dec 31, 2024 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| NuCana | 12 |
| Processa Pharmaceuticals | 12 |
| Lexaria Bioscience | 7 |
| Ernexa Therapeutics | 7 |
| Enveric Biosciences | 6 |
KAPA News
- 3 days ago - Kairos Pharma Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 3 days ago - Kairos Pharma Slides: Investor presentation - Filings
- 8 days ago - Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 27 days ago - Kairos Pharma announces 1-for-7 reverse stock split - TheFly
- 27 days ago - Kairos Pharma Announces 1-for-7 Reverse Stock Split - Business Wire
- 5 weeks ago - Kairos Pharma Quarterly report: Q2 2026 - Filings
- 1 month ago - Kairos Pharma announces collaboration with Bayer to enhance XOFIGO - TheFly
- 1 month ago - Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer - Business Wire